Amphastar Pharmaceuticals, Inc.

$19.1
USD
Last updated on --.
24h volume436.96K
24h highest19.6360 USD
24h lowest18.4850 USD
24h Price movement+1.54%

AMPH recent prices

24 Hours
+1.54%+$0.29
30 days
-12.47%-$2.720
60 days
-0.62%-$0.12
90 days
-5.59%-$1.130

Key data

Previous close18.8100 USD
Market cap797.20M USD
Volume436.96K
P/E ratio10.060000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)1.8000 USD
Net income (FY)79.23M USD
Revenue (FY)720.53M USD
Last report dateMay 7, 2026

About Amphastar Pharmaceuticals, Inc.

PHARMACEUTICAL PREPARATIONS
HeadquartersRANCHO CUCAMONGA
Employees (FY)1.98K
Revenue per employee (FY)364.64K USD
Net income per employee (FY)40.10K USD
Listed onNasdaq
Official website

AMPH conversion tables

AMPHAMPH
USDUSD
0.5 AMPH9.550 USD
1 AMPH19.1 USD
5 AMPH95.5 USD
10 AMPH191 USD
USDUSD
AMPHAMPH
0.5 USD0.026178 AMPH
1 USD0.052356 AMPH
5 USD0.26178 AMPH
10 USD0.52356 AMPH

FAQ

AMPH is trading at $19.10, +1.54% over the last 24 hours. Track live moves on the price chart at the top of this page.
The AMPH stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. AMPH is currently trading at $19.10, +1.54% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on AMPH price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. AMPH's P/E ratio is currently 10.060000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from AMPH; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against AMPH's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Amphastar Pharmaceuticals, Inc.'s market cap is currently 797.20M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume436.96K
24h highest19.6360 USD
24h lowest18.4850 USD
24h Price movement+1.54%
AMPHAMPH
USDUSD
Start trade with AMPH Perpetual